Patient info

A16AX06 miglustat

ATC group of level 5 – chemical substance · in plain English: medicines for rare metabolic diseases

This site has the patient leaflet or the SPC of 7 medicines in this group.

Active substance: Miglustat – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. A Alimentary tract and metabolism drugs 1,624 medicines
    1. A16 Other alimentary tract and metabolism products 95 medicines
      1. A16A Other alimentary tract and metabolism products 95 medicines
        1. A16AX Various alimentary tract and metabolism products 50 medicines
          1. A16AX06 miglustat 7 medicines

Medicines

MedicineLegal category
Miglustat 100 mg hard capsules SPC Prescription only (POM)
Miglustat Dipharma SPC –
Miglustat Dipharma 100 mg hard capsules SPC Prescription only (POM)
Miglustat Gen.Orph 100 mg hard capsules SPC Prescription only (POM)
Opfolda 65 mg hard capsules SPC Prescription only (POM)
Yargesa 100 mg hard capsules SPC Prescription only (POM)
Zavesca 100 mg capsules SPC Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group A16AX06

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.